

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.88777657 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.75690070 |
| 3 | lipoprotein transport (GO:0042953) | 7.72351703 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.08718885 |
| 5 | NADH metabolic process (GO:0006734) | 6.94896647 |
| 6 | regulation of bile acid biosynthetic process (GO:0070857) | 6.79858285 |
| 7 | intestinal absorption (GO:0050892) | 6.72595321 |
| 8 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.64961456 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.20339820 |
| 10 | hormone catabolic process (GO:0042447) | 5.68700449 |
| 11 | fructose metabolic process (GO:0006000) | 5.48980013 |
| 12 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.48901751 |
| 13 | endocrine process (GO:0050886) | 5.48901751 |
| 14 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.48901751 |
| 15 | drug metabolic process (GO:0017144) | 5.16033555 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 5.12499002 |
| 17 | virion attachment to host cell (GO:0019062) | 5.10505019 |
| 18 | adhesion of symbiont to host cell (GO:0044650) | 5.10505019 |
| 19 | regulation of systemic arterial blood pressure (GO:0003073) | 4.97095637 |
| 20 | peptide hormone processing (GO:0016486) | 4.79313081 |
| 21 | regulation of cellular extravasation (GO:0002691) | 4.79189292 |
| 22 | regulation of cGMP biosynthetic process (GO:0030826) | 4.70826944 |
| 23 | cellular glucuronidation (GO:0052695) | 4.70207281 |
| 24 | glucuronate metabolic process (GO:0019585) | 4.62635233 |
| 25 | uronic acid metabolic process (GO:0006063) | 4.62635233 |
| 26 | vitamin A metabolic process (GO:0006776) | 4.54313981 |
| 27 | digestion (GO:0007586) | 4.50508428 |
| 28 | diacylglycerol metabolic process (GO:0046339) | 4.49431666 |
| 29 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.44310485 |
| 30 | peptide catabolic process (GO:0043171) | 4.43239135 |
| 31 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.40283874 |
| 32 | urea cycle (GO:0000050) | 4.39514708 |
| 33 | bile acid and bile salt transport (GO:0015721) | 4.39461735 |
| 34 | adhesion of symbiont to host (GO:0044406) | 4.29467544 |
| 35 | urea metabolic process (GO:0019627) | 4.23543378 |
| 36 | glycolipid catabolic process (GO:0019377) | 4.21238470 |
| 37 | flavonoid metabolic process (GO:0009812) | 4.19172055 |
| 38 | glycosphingolipid catabolic process (GO:0046479) | 4.18976370 |
| 39 | vitamin transmembrane transport (GO:0035461) | 4.12698521 |
| 40 | renal system process involved in regulation of blood volume (GO:0001977) | 4.11374201 |
| 41 | plasma lipoprotein particle assembly (GO:0034377) | 4.04642023 |
| 42 | regulation of vitamin metabolic process (GO:0030656) | 4.03637564 |
| 43 | drinking behavior (GO:0042756) | 3.98130407 |
| 44 | regulation of cGMP metabolic process (GO:0030823) | 3.96569027 |
| 45 | fat-soluble vitamin metabolic process (GO:0006775) | 3.95282214 |
| 46 | lipoprotein metabolic process (GO:0042157) | 3.91909995 |
| 47 | vitamin transport (GO:0051180) | 3.91033591 |
| 48 | antibacterial humoral response (GO:0019731) | 3.89673826 |
| 49 | cellular response to nitric oxide (GO:0071732) | 3.89163140 |
| 50 | alkaloid metabolic process (GO:0009820) | 3.85958856 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.84817193 |
| 52 | drug catabolic process (GO:0042737) | 3.82689100 |
| 53 | mRNA modification (GO:0016556) | 3.79378591 |
| 54 | antimicrobial humoral response (GO:0019730) | 3.76401824 |
| 55 | homocysteine metabolic process (GO:0050667) | 3.69852360 |
| 56 | exogenous drug catabolic process (GO:0042738) | 3.66101504 |
| 57 | protein-lipid complex assembly (GO:0065005) | 3.61431653 |
| 58 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.60652384 |
| 59 | cGMP biosynthetic process (GO:0006182) | 3.59938609 |
| 60 | regulation of protein glycosylation (GO:0060049) | 3.59786621 |
| 61 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.58953839 |
| 62 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.49702706 |
| 63 | positive regulation of pseudopodium assembly (GO:0031274) | 3.46552937 |
| 64 | midgut development (GO:0007494) | 3.45634698 |
| 65 | ceramide catabolic process (GO:0046514) | 3.45133958 |
| 66 | glycerol metabolic process (GO:0006071) | 3.45049989 |
| 67 | bile acid metabolic process (GO:0008206) | 3.43726218 |
| 68 | cellular response to reactive nitrogen species (GO:1902170) | 3.42042498 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39885029 |
| 70 | auditory receptor cell differentiation (GO:0042491) | 3.38710153 |
| 71 | sulfate transmembrane transport (GO:1902358) | 3.37600633 |
| 72 | drug transport (GO:0015893) | 3.36594045 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35651421 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35651421 |
| 75 | phospholipid efflux (GO:0033700) | 3.34629428 |
| 76 | sphingomyelin metabolic process (GO:0006684) | 3.34462816 |
| 77 | cytidine deamination (GO:0009972) | 3.34347690 |
| 78 | cytidine metabolic process (GO:0046087) | 3.34347690 |
| 79 | cytidine catabolic process (GO:0006216) | 3.34347690 |
| 80 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.33782379 |
| 81 | urate metabolic process (GO:0046415) | 3.33214388 |
| 82 | vitamin biosynthetic process (GO:0009110) | 3.32452439 |
| 83 | glycosylceramide metabolic process (GO:0006677) | 3.31843248 |
| 84 | response to nitric oxide (GO:0071731) | 3.31328236 |
| 85 | heme transport (GO:0015886) | 3.28531203 |
| 86 | sphingolipid catabolic process (GO:0030149) | 3.26610893 |
| 87 | cobalamin metabolic process (GO:0009235) | 3.26581898 |
| 88 | digestive system process (GO:0022600) | 3.25859154 |
| 89 | vitamin D metabolic process (GO:0042359) | 3.22533125 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.22070466 |
| 91 | arginine metabolic process (GO:0006525) | 3.21106003 |
| 92 | sulfur compound transport (GO:0072348) | 3.17869861 |
| 93 | glomerulus development (GO:0032835) | 3.17794606 |
| 94 | positive regulation of cGMP metabolic process (GO:0030825) | 3.17145482 |
| 95 | sexual reproduction (GO:0019953) | 3.15474664 |
| 96 | membrane lipid catabolic process (GO:0046466) | 3.11976558 |
| 97 | actin filament depolymerization (GO:0030042) | 3.11242358 |
| 98 | regulation of pseudopodium assembly (GO:0031272) | 3.11036807 |
| 99 | drug transmembrane transport (GO:0006855) | 3.10511073 |
| 100 | angiotensin maturation (GO:0002003) | 11.6532222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.05828991 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.94014757 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75795388 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.26062519 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.23548008 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.94614737 |
| 7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.70303281 |
| 8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.62811997 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.50003581 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42296079 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37154145 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.35404082 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28991590 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.27240265 |
| 15 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.23550668 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.11588652 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11216940 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.04464828 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02484563 |
| 20 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86664075 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75040289 |
| 22 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.74002341 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73218626 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71611167 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71091182 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69780625 |
| 27 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.64266287 |
| 28 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.55474771 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54721523 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51002664 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50742516 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45421774 |
| 33 | RXR_22108803_ChIP-Seq_LS180_Human | 1.40969897 |
| 34 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39641847 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39640056 |
| 36 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.34330780 |
| 37 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28567636 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24589100 |
| 39 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15332700 |
| 40 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14741044 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12778100 |
| 42 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12322925 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11001738 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06026146 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05775734 |
| 46 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05115894 |
| 47 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04845458 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02914436 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02133638 |
| 50 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02067761 |
| 51 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01781927 |
| 52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98986945 |
| 53 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98407183 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98212868 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97567741 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97360547 |
| 57 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96064300 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95100670 |
| 59 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.94999622 |
| 60 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94771495 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93464750 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93428338 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90936914 |
| 64 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90642815 |
| 65 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88453663 |
| 66 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88155869 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87216608 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86898919 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86746524 |
| 70 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.86063201 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85342045 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84884895 |
| 73 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84102521 |
| 74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83744464 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82711717 |
| 76 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82497167 |
| 77 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82497051 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 0.82404429 |
| 79 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.82366518 |
| 80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82306233 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82140847 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81171891 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80884558 |
| 84 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.79578816 |
| 85 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.79310194 |
| 86 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79213078 |
| 87 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78946320 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78829002 |
| 89 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78366554 |
| 90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75681241 |
| 91 | NFYA_21822215_ChIP-Seq_K562_Human | 0.75129035 |
| 92 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.74914243 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74490484 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74469295 |
| 95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73668730 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73666807 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73049160 |
| 98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72890981 |
| 99 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.72489443 |
| 100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.72489443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.61529008 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.08996259 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.96494737 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.64326536 |
| 5 | MP0004147_increased_porphyrin_level | 4.05132651 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.89055840 |
| 7 | MP0005365_abnormal_bile_salt | 3.88333976 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.50283597 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 3.40767005 |
| 10 | MP0009840_abnormal_foam_cell | 3.37954889 |
| 11 | MP0009379_abnormal_foot_pigmentation | 3.22647055 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.53684745 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.40527673 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.36585551 |
| 15 | MP0005409_darkened_coat_color | 2.06517062 |
| 16 | MP0005332_abnormal_amino_acid | 1.96725039 |
| 17 | MP0001664_abnormal_digestion | 1.94792158 |
| 18 | MP0009643_abnormal_urine_homeostasis | 1.86260605 |
| 19 | MP0003252_abnormal_bile_duct | 1.83375342 |
| 20 | MP0000538_abnormal_urinary_bladder | 1.78780878 |
| 21 | MP0003866_abnormal_defecation | 1.74002561 |
| 22 | MP0003868_abnormal_feces_composition | 1.72701871 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.70983760 |
| 24 | MP0001764_abnormal_homeostasis | 1.61050270 |
| 25 | MP0000490_abnormal_crypts_of | 1.55553497 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.52387075 |
| 27 | MP0005670_abnormal_white_adipose | 1.51392073 |
| 28 | MP0003718_maternal_effect | 1.49679138 |
| 29 | MP0005166_decreased_susceptibility_to | 1.39846249 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.38221840 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.35891060 |
| 32 | MP0003879_abnormal_hair_cell | 1.34158923 |
| 33 | MP0001188_hyperpigmentation | 1.30155757 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.29004334 |
| 35 | MP0005448_abnormal_energy_balance | 1.27853219 |
| 36 | MP0000477_abnormal_intestine_morphology | 1.25905639 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.25851815 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.23913181 |
| 39 | MP0004270_analgesia | 1.21872144 |
| 40 | MP0000678_abnormal_parathyroid_gland | 1.20469937 |
| 41 | MP0002136_abnormal_kidney_physiology | 1.20207328 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.17738610 |
| 43 | MP0002822_catalepsy | 1.14097243 |
| 44 | MP0005535_abnormal_body_temperature | 1.08847036 |
| 45 | MP0002971_abnormal_brown_adipose | 1.07779794 |
| 46 | MP0001873_stomach_inflammation | 1.01264065 |
| 47 | MP0001485_abnormal_pinna_reflex | 0.98280187 |
| 48 | MP0004858_abnormal_nervous_system | 0.97820506 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95160467 |
| 50 | MP0000462_abnormal_digestive_system | 0.95153773 |
| 51 | MP0001756_abnormal_urination | 0.94557199 |
| 52 | MP0000609_abnormal_liver_physiology | 0.94091879 |
| 53 | MP0001663_abnormal_digestive_system | 0.92646145 |
| 54 | MP0000230_abnormal_systemic_arterial | 0.92365752 |
| 55 | MP0004043_abnormal_pH_regulation | 0.90742760 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 0.87987559 |
| 57 | MP0009115_abnormal_fat_cell | 0.87254058 |
| 58 | MP0005174_abnormal_tail_pigmentation | 0.85297270 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 0.85252370 |
| 60 | MP0001845_abnormal_inflammatory_respons | 0.77561393 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 0.76338439 |
| 62 | MP0008469_abnormal_protein_level | 0.75091941 |
| 63 | MP0005381_digestive/alimentary_phenotyp | 0.73789397 |
| 64 | MP0009642_abnormal_blood_homeostasis | 0.73603830 |
| 65 | MP0008872_abnormal_physiological_respon | 0.71132011 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.61997006 |
| 67 | MP0003045_fibrosis | 0.60738156 |
| 68 | MP0006138_congestive_heart_failure | 0.60430000 |
| 69 | MP0008875_abnormal_xenobiotic_pharmacok | 0.59380861 |
| 70 | MP0005451_abnormal_body_composition | 0.59211629 |
| 71 | MP0009764_decreased_sensitivity_to | 0.58907346 |
| 72 | MP0003953_abnormal_hormone_level | 0.57237781 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.57184699 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.56836556 |
| 75 | MP0005395_other_phenotype | 0.56570449 |
| 76 | MP0000249_abnormal_blood_vessel | 0.55270236 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 0.54837593 |
| 78 | MP0000516_abnormal_urinary_system | 0.54551044 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 0.54551044 |
| 80 | MP0006082_CNS_inflammation | 0.54457955 |
| 81 | MP0002166_altered_tumor_susceptibility | 0.54135737 |
| 82 | MP0009785_altered_susceptibility_to | 0.54086552 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.52921042 |
| 84 | MP0005334_abnormal_fat_pad | 0.50585055 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.49797955 |
| 86 | MP0004484_altered_response_of | 0.46365910 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.45342534 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.44730216 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.42088736 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.41906753 |
| 91 | MP0003724_increased_susceptibility_to | 0.40224300 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.39999091 |
| 93 | MP0008775_abnormal_heart_ventricle | 0.39600623 |
| 94 | MP0002796_impaired_skin_barrier | 0.39447217 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.38977938 |
| 96 | MP0002135_abnormal_kidney_morphology | 0.38413003 |
| 97 | MP0001835_abnormal_antigen_presentation | 0.38236388 |
| 98 | MP0002909_abnormal_adrenal_gland | 0.37925952 |
| 99 | MP0000427_abnormal_hair_cycle | 0.37019812 |
| 100 | MP0005310_abnormal_salivary_gland | 0.36872879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of proline metabolism (HP:0010907) | 7.68319117 |
| 2 | Hydroxyprolinuria (HP:0003080) | 7.68319117 |
| 3 | Malnutrition (HP:0004395) | 7.28854330 |
| 4 | Chronic diarrhea (HP:0002028) | 6.14316511 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.13414729 |
| 6 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.58201998 |
| 7 | Abnormality of vitamin B metabolism (HP:0004340) | 5.38386074 |
| 8 | Acanthocytosis (HP:0001927) | 5.33684793 |
| 9 | Ileus (HP:0002595) | 5.00239571 |
| 10 | Fat malabsorption (HP:0002630) | 4.93469715 |
| 11 | Widely patent fontanelles and sutures (HP:0004492) | 4.73316343 |
| 12 | Confusion (HP:0001289) | 4.54291289 |
| 13 | Hyperglycinuria (HP:0003108) | 4.46254823 |
| 14 | Abnormality of vitamin metabolism (HP:0100508) | 4.20242174 |
| 15 | Glycosuria (HP:0003076) | 4.11510095 |
| 16 | Abnormality of urine glucose concentration (HP:0011016) | 4.11510095 |
| 17 | Pigmentary retinal degeneration (HP:0001146) | 4.09687220 |
| 18 | Nausea (HP:0002018) | 3.70296264 |
| 19 | Proximal tubulopathy (HP:0000114) | 3.69409171 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.63868591 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.60487949 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.60487949 |
| 23 | Decreased circulating renin level (HP:0003351) | 3.42591243 |
| 24 | Wide cranial sutures (HP:0010537) | 3.41867761 |
| 25 | Facial shape deformation (HP:0011334) | 3.41531401 |
| 26 | Potter facies (HP:0002009) | 3.41531401 |
| 27 | Nephrolithiasis (HP:0000787) | 3.34153305 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.31784244 |
| 29 | Xanthomatosis (HP:0000991) | 3.27245650 |
| 30 | Thin bony cortex (HP:0002753) | 3.24865783 |
| 31 | Megaloblastic anemia (HP:0001889) | 3.15235406 |
| 32 | Steatorrhea (HP:0002570) | 3.11986660 |
| 33 | Hyperuricemia (HP:0002149) | 3.09903160 |
| 34 | Increased purine levels (HP:0004368) | 3.09903160 |
| 35 | Posterior subcapsular cataract (HP:0007787) | 3.08240195 |
| 36 | Abdominal distention (HP:0003270) | 2.98188987 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.95558710 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.95370724 |
| 39 | Alkalosis (HP:0001948) | 2.90257614 |
| 40 | Hyperactive renin-angiotensin system (HP:0000841) | 2.86668283 |
| 41 | Metabolic alkalosis (HP:0200114) | 2.85350616 |
| 42 | Epidermoid cyst (HP:0200040) | 2.84274342 |
| 43 | Hypophosphatemia (HP:0002148) | 2.83916506 |
| 44 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.76344389 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.75385236 |
| 46 | Abnormal urine phosphate concentration (HP:0012599) | 2.70309868 |
| 47 | Enlarged epiphyses (HP:0010580) | 2.66206759 |
| 48 | Hyperphosphaturia (HP:0003109) | 2.59420503 |
| 49 | Hyperammonemia (HP:0001987) | 2.58404194 |
| 50 | Abnormality of renin-angiotensin system (HP:0000847) | 2.49803106 |
| 51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.48020220 |
| 52 | Hyperparathyroidism (HP:0000843) | 2.47086412 |
| 53 | Focal segmental glomerulosclerosis (HP:0000097) | 2.41803640 |
| 54 | Hypotension (HP:0002615) | 2.40491007 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38927007 |
| 56 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.35275912 |
| 57 | Villous atrophy (HP:0011473) | 2.35275912 |
| 58 | Abnormal glucose tolerance (HP:0001952) | 2.33142494 |
| 59 | Subcapsular cataract (HP:0000523) | 2.30980319 |
| 60 | Poikilocytosis (HP:0004447) | 2.29877642 |
| 61 | Metabolic acidosis (HP:0001942) | 2.29253438 |
| 62 | Delayed epiphyseal ossification (HP:0002663) | 2.27277146 |
| 63 | Abnormality of the costochondral junction (HP:0000919) | 2.23294718 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.20488810 |
| 65 | Gout (HP:0001997) | 2.19805898 |
| 66 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16885571 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.15260906 |
| 68 | Abnormal albumin level (HP:0012116) | 2.10777256 |
| 69 | Hypoalbuminemia (HP:0003073) | 2.10777256 |
| 70 | Protuberant abdomen (HP:0001538) | 2.01896674 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.00011094 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00011094 |
| 73 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.9768715 |
| 74 | Generalized aminoaciduria (HP:0002909) | 1.96593722 |
| 75 | Irritability (HP:0000737) | 1.95552766 |
| 76 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94410583 |
| 77 | Hyperphosphatemia (HP:0002905) | 1.93972452 |
| 78 | Pancreatitis (HP:0001733) | 1.93365497 |
| 79 | Renal tubular acidosis (HP:0001947) | 1.92498698 |
| 80 | Gastrointestinal dysmotility (HP:0002579) | 1.91159451 |
| 81 | Hemorrhage of the eye (HP:0011885) | 1.85652249 |
| 82 | Glomerulosclerosis (HP:0000096) | 1.84636705 |
| 83 | Abnormal biliary tract morphology (HP:0012440) | 1.83420277 |
| 84 | Cerebral palsy (HP:0100021) | 1.82161883 |
| 85 | Petechiae (HP:0000967) | 1.81409728 |
| 86 | White forelock (HP:0002211) | 1.81390763 |
| 87 | Chorioretinal atrophy (HP:0000533) | 1.81090245 |
| 88 | Renal tubular dysfunction (HP:0000124) | 1.78206143 |
| 89 | Glomerulonephritis (HP:0000099) | 1.76299292 |
| 90 | Dehydration (HP:0001944) | 1.75715470 |
| 91 | Gingivitis (HP:0000230) | 1.73746428 |
| 92 | Biliary tract neoplasm (HP:0100574) | 1.72184682 |
| 93 | Patchy hypopigmentation of hair (HP:0011365) | 1.71990281 |
| 94 | Multiple lipomas (HP:0001012) | 1.71617195 |
| 95 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68971020 |
| 96 | Hypocalcemia (HP:0002901) | 1.68207862 |
| 97 | Lethargy (HP:0001254) | 1.67441811 |
| 98 | Symptomatic seizures (HP:0011145) | 1.64733418 |
| 99 | Hypokalemia (HP:0002900) | 1.60890980 |
| 100 | Metaphyseal irregularity (HP:0003025) | 1.60632618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.16951436 |
| 2 | MST1R | 3.70643081 |
| 3 | ERN1 | 3.54974893 |
| 4 | PRKG2 | 3.43411481 |
| 5 | MAP3K10 | 2.99769914 |
| 6 | RIPK1 | 2.71889576 |
| 7 | STK39 | 2.53829956 |
| 8 | EPHA3 | 2.30244885 |
| 9 | OXSR1 | 2.17485572 |
| 10 | EPHA2 | 2.06971327 |
| 11 | MAP3K2 | 2.01864003 |
| 12 | STK38L | 1.96132610 |
| 13 | PDK2 | 1.88434965 |
| 14 | AKT3 | 1.84657104 |
| 15 | LATS1 | 1.74820094 |
| 16 | FRK | 1.72844550 |
| 17 | FGFR4 | 1.58864568 |
| 18 | MST4 | 1.57190923 |
| 19 | NLK | 1.54348222 |
| 20 | TNIK | 1.49734810 |
| 21 | TYK2 | 1.42709976 |
| 22 | EPHA4 | 1.40933893 |
| 23 | EPHB2 | 1.38792709 |
| 24 | MET | 1.36116868 |
| 25 | PTK6 | 1.30192919 |
| 26 | MAP3K12 | 1.30171613 |
| 27 | DDR2 | 1.25250558 |
| 28 | STK24 | 1.17524590 |
| 29 | TESK2 | 1.15231228 |
| 30 | FGFR3 | 1.10409774 |
| 31 | MAP2K2 | 1.04072823 |
| 32 | GRK6 | 1.03927551 |
| 33 | EPHB1 | 1.00796627 |
| 34 | PIK3CA | 0.99196850 |
| 35 | MYLK | 0.98821877 |
| 36 | IRAK1 | 0.98403152 |
| 37 | MAP3K1 | 0.97544926 |
| 38 | MATK | 0.95814004 |
| 39 | FER | 0.94930632 |
| 40 | PRKAA2 | 0.91220112 |
| 41 | MAP4K1 | 0.91040084 |
| 42 | PDPK1 | 0.91039508 |
| 43 | ERBB2 | 0.83181305 |
| 44 | PIM1 | 0.76388408 |
| 45 | STK38 | 0.76139177 |
| 46 | MAP2K6 | 0.76094238 |
| 47 | STK3 | 0.73326361 |
| 48 | PRKACG | 0.71394040 |
| 49 | PRPF4B | 0.71031164 |
| 50 | CASK | 0.70321749 |
| 51 | GRK1 | 0.68034087 |
| 52 | CDC42BPA | 0.61734065 |
| 53 | TESK1 | 0.60685706 |
| 54 | DAPK2 | 0.58070727 |
| 55 | PDK1 | 0.56849871 |
| 56 | PRKCA | 0.55864812 |
| 57 | PRKCZ | 0.55489171 |
| 58 | RIPK4 | 0.55101798 |
| 59 | MAPK11 | 0.54329696 |
| 60 | BMPR2 | 0.53654207 |
| 61 | PIK3CG | 0.53314391 |
| 62 | YES1 | 0.52972919 |
| 63 | LMTK2 | 0.48425620 |
| 64 | CAMK2D | 0.47859438 |
| 65 | NEK1 | 0.47415212 |
| 66 | JAK1 | 0.45189282 |
| 67 | NEK6 | 0.44921002 |
| 68 | TAOK1 | 0.43177503 |
| 69 | ABL2 | 0.42782446 |
| 70 | MELK | 0.41850649 |
| 71 | PRKCD | 0.38796142 |
| 72 | SRC | 0.38368846 |
| 73 | DYRK1B | 0.38291210 |
| 74 | ITK | 0.36808117 |
| 75 | MAP3K3 | 0.35951898 |
| 76 | CAMK2G | 0.35679692 |
| 77 | TEC | 0.34071530 |
| 78 | PDGFRA | 0.33659047 |
| 79 | RET | 0.32629791 |
| 80 | CAMK2B | 0.32114293 |
| 81 | TGFBR2 | 0.32066719 |
| 82 | FYN | 0.31024422 |
| 83 | JAK2 | 0.28264372 |
| 84 | BTK | 0.27821769 |
| 85 | PRKACA | 0.25921731 |
| 86 | MAPK13 | 0.25894084 |
| 87 | CSF1R | 0.25830583 |
| 88 | PTK2 | 0.25404572 |
| 89 | ADRBK2 | 0.25057525 |
| 90 | MAP3K11 | 0.23457652 |
| 91 | BCR | 0.23002898 |
| 92 | IGF1R | 0.20756769 |
| 93 | CDK19 | 0.20464870 |
| 94 | PRKCI | 0.20314542 |
| 95 | CAMK2A | 0.19406586 |
| 96 | KIT | 0.19165355 |
| 97 | SYK | 0.18475029 |
| 98 | IRAK2 | 0.18423943 |
| 99 | ERBB3 | 0.18195379 |
| 100 | IKBKE | 0.16775920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.10928866 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.92509556 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.48492745 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.23587177 |
| 5 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.74083301 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.64955493 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.59537398 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.49481514 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43958757 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.33045956 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19341159 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.14915347 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.02636345 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02360594 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96427628 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.95623586 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93554532 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.90517801 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87528112 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.84971232 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.82651679 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74389687 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.70598375 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69330155 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.63346056 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.62496635 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.58260775 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52711043 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.47805399 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47017944 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38551355 |
| 32 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36385807 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35700354 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32748396 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23871117 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.11543884 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08286886 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.07335604 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04194374 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03160296 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96043884 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91681143 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87065308 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79482477 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76495881 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73230163 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70642165 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65108827 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.65086274 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61717162 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61553007 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60384148 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59233170 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56906158 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52138755 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50526535 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.49383175 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48343983 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44989145 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.43143328 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.40627639 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36249572 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35731328 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34036648 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.33853326 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28701926 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28658600 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.26945871 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24464005 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24363432 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24061676 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23705655 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23231151 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22850032 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.19525485 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.15609952 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13953370 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.13126774 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.13067415 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12540138 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.11560559 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.10345144 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08622144 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07928942 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.07086360 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.06615914 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.06417275 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.04959002 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.03495800 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.03401165 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.03193119 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.01682748 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.01346870 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.01346505 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.01308756 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.00189519 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0172014 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0142260 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0021152 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0012338 |

